Member Info for Nolupus

Leas ,

Leas , We had quite a few run ins Pre results , you and me which you seem to have forgotten….I was branded a heretic for pointing out the flaws in that P3 trial … but whatever ..

People are reacting to the fall in the SP , but Tim cannot put out any RNS until such time as he has a concrete plan of action / or that he has exhausted all possibilities, imo …

Rumors that Radar is buying Stock :-)

Cuvio,

Sorry but If one looks objectively at things , one cannot say that the pandemic is the cause of the lack of progress during the last 3 years. Even Murphy’s law cannot explain it, imo

Cuvio,

If this was another company , I would probably agree with you :-)

With hindsight, what seems simple is in reality very complicated, like the 3 year period to begin the P3 ( N2 )

Cuvio,

Could you elaborate on what you mean ?

What steps ?

I do think that the next steps towards the P3 trial are being worked on.

IMM , would have had to inform the market if talks of a takeover were being held , imo , so personally I rule out that scenario

This whole situation has a hint of scandal to it , no matter what outcome , imo

Three years have gone by since IMM signed the agreement with Avion … 3 years for what results ?

Was has been achieved in this long period ?

Dallo,
The stakes are high and the lack of news is painful .

Will Avion decide that further trials will take too long and too expensive for them ?
Will IMM drop the Lupus indication to concentrate their limited ressources on CIDP ?
Will Tim pull a rabbit out of his hat ?

Many questions but the lack of ressources has put IMM’s back against a wall , imo , so they need someone with deep pockets to save the situation, is my view ( for what it’s worth ) …

ATB …

SYNGOLD,

I think you should heed your own words … which were

Any original thoughts ?????? Sometimes, it’s better to keep your mouth shut and give the impression that you’re stupid, rather than open it and remove all doubt. If you have an opinion, raise your hand. Then, after raising your hand, put it in your mouth.

Some observers are expecting a bid whilst others are considering more sombre possibilities….

We have no choice but to await the conclusions of all the negotiations that are going on ..

It’s very much a binary situation at this time, imo

Hope for the best but be prepared for the worst …

Maid308,

Sorry for your Loss …

Plenty original and logical posts if one takes the time to read but unfortunately people seem to read only strong buy posts . Contrarian thinking is frowned upon but whatever , that’s human nature .

Best of luck

Maidit308,

Ignorance and foul language is something you share with our strong buy Frits …

I wish you a great life together !

Maidit308 ,

In response to your summary, which was

In summary, the FDA response earlier this month, recommended assessing the potential to use higher dosing in the next clinical program of Lupuzor™ in Lupus, to optimise the clinical benefit to Lupus patients and to maximise efficacy. In addition, the FDA made additional recommendations on clinical measurements, again to support Lupuzor™ through the regulatory process to approval.

Could you give any examples of any company that changed their dosage levels in a P3 trial ??

If you find one, please let me know ..

As for Strong buy Frits , please take his advice as he has been proved right since he gave strong buy advice at 180p, 150p, 120p, 60p , 40p , 20p, 10p, 5p, etc etc
One day, odds are that he will be right but after many years of strong buy recommendations, he should be asking himself , how many people have I ruined with my strong buys, and insights ??

Maidit308,

If you are capable of reading between the lines on a post here , you should also be able to do the same on a RNS , imo

TrustIlie,

Why not 30-40-50p ?

You should try pumping it more , ten bagger easy :-))

Why is it wrong Dallo ?

They are insiders and therefore are subjected to confidentiality clauses and other obligations.
Yes, they know what is going on but they cannot use that knowledge to trade/invest/divest etc

This is taking a long time to iron out for sure but the ramifications of these discussions are HUGE , imo , so we will just have to wait for the outcomes , be they positive or negative…

I think that was 3.76 Trojan :-)

Hopefully we won’t be seeing 1.76 …

Let’s see what news is incoming as so far it’s been pretty dismal

I would imagine that it’s not just a matter of Avion/IMM at this time . The other stakeholders like the CNRS etc need consulting as well , imo
The changes to the formulation as well as patent protection are the major considerations, imo